<DOC>
	<DOCNO>NCT01418729</DOCNO>
	<brief_summary>The purpose study evaluate overall survival ( OS ) order ass efficacy safety pravastatin adjuvant treatment sorafenib .</brief_summary>
	<brief_title>Efficacy Safety Study Sorafenib Plus Pravastatin Treat Advanced Hepatocarcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Sorafenib</mesh_term>
	<mesh_term>Pravastatin</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<criteria>Patients diagnose advanced hepatocarcinoma ( HCC ) , confirm histologically noninvasive criterion , accord clinical practice guideline American Association Study Liver Diseases ( AASLD ) maximum period 15 day prior baseline visit . Males female , 18 year age . Patients previously receive treatment sorafenib . Have ECOG â‰¤ 2 . Liver function : Child A B7 . Life expectancy great 12 week . Adequate kidney function : serum creatinine concentration less equal 1.5 time upper limit normal ( ULN ) . Sign write informed consent start procedure , include randomization . Patients routinely ( 3 time week ) take sort statin . Patients hypersensitivity statin . Pregnant breastfeed woman . Peripheral neuropathy : grade 2 high Patients diagnose , within previous 5 year , another type tumor , except nonmelanoma skin cancer , situ carcinoma cervix urinary bladder . Patients receive chemotherapy radiotherapy another type tumor . Patients heart failure great NYHA grade II , hypertension uncontrolled medication , uncontrolled arrhythmia AMI within previous six month . A history perforation hemorrhage due gastroduodenal ulcus within last month . Greater hemorrhagic disease . Asthmatic patient uncontrolled medication . Any contraindication associate use statin . Physical psychological inability participate trial . Treatment another investigational drug participation another clinical trial within 6 month prior inclusion study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>